Publications by authors named "Rakesh Wahi"

Claim this Profile
S
Safety and efficacy of thrombin-JMI: a multidisciplinary expert group consensus.
Mohit Bhandari, Frederick A Ofosu, Nigel Mackman, Craig Jackson, Cataldo Doria, Rakesh Wahi

Clin Appl Thromb Hemost· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
David Van Thiel, Evi Kalodiki, Rakesh Wahi, Evan Litinas, Wasimul Haque

Clin Appl Thromb Hemost· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic application.
He Zhu, Debra Hoppensteadt, Rakesh Wahi, Josephine Cunanan, Cafer Adiguzel

Clin Appl Thromb Hemost· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
Jawed Fareed, Walter Jeske, Daniel Fareed, Melaine Clark, Rakesh Wahi

Clin Appl Thromb Hemost· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contaminated heparin preparations, severe adverse events and the contact system.
Eduardo Ramacciotti, Rakesh Wahi, Harry L Messmore

Clin Appl Thromb Hemost· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contaminant in the recalled unfractionated heparin preparations: where is the problem?
Debra A Hoppensteadt, Rakesh Wahi, Cafer Adiguzel, Omer Iqbal, Eduardo Ramacciotti

Clin Appl Thromb Hemost· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Jawed Fareed, Debra A Hoppensteadt, Daniel Fareed, Muzaffer Demir, Rakesh Wahi

Semin Thromb Hemost· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Jyothi Maddineni, Jeanine M Walenga, Walter P Jeske, Debra A Hoppensteadt, Jawed Fareed, Rakesh Wahi

Clin Appl Thromb Hemost· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generic low molecular weight heparins: a significant dilemma.
Jawed Fareed, Omer Iqbal, Helena Nader, Shaker Mousa, Rakesh Wahi

Clin Appl Thromb Hemost· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis